Fiera Capital Corp Veracyte, Inc. Transaction History

Fiera Capital Corp

$30.3 Billion
Q4 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$18.86 - $23.55 $136,150 - $170,007	7,219 Added 1.17%	625,536 $13.6 Million
Q1 2024 Aug 22, 2024	SELL	$21.0 - $29.1 $151,599 - $210,072	-7,219 Reduced 1.15%	618,317 $13.7 Million
Q1 2024 May 01, 2024	SELL	$21.0 - $29.1 $419,643 - $581,505	-19,983 Reduced 3.13%	618,317 $13.7 Million
Q4 2023 Aug 22, 2024	BUY	$19.72 - $28.68 $60,382 - $87,818	3,062 Added 0.48%	638,300 $17.6 Million
Q4 2023 Feb 08, 2024	BUY	$19.72 - $28.68 $60,382 - $87,818	3,062 Added 0.48%	638,300 $17.6 Million
Q3 2023 Aug 22, 2024	BUY	$22.33 - $29.92 $216,645 - $290,283	9,702 Added 1.55%	635,238 $14.2 Million
Q3 2023 Nov 09, 2023	BUY	$22.33 - $29.92 $289,084 - $387,344	12,946 Added 2.08%	635,238 $14.2 Million
Q2 2023 Aug 09, 2023	SELL	$20.96 - $26.99 $332,236 - $427,818	-15,851 Reduced 2.48%	622,292 $15.8 Million
Q1 2023 Apr 26, 2023	SELL	$20.58 - $27.89 $206,746 - $280,182	-10,046 Reduced 1.55%	638,143 $14.2 Million
Q4 2022 Feb 08, 2023	SELL	$15.31 - $29.94 $41,765 - $81,676	-2,728 Reduced 0.42%	648,189 $15.4 Million
Q3 2022 Nov 03, 2022	SELL	$16.58 - $27.9 $157,725 - $265,412	-9,513 Reduced 1.44%	650,917 $9.73 Million
Q2 2022 Aug 10, 2022	SELL	$15.45 - $29.52 $242,086 - $462,548	-15,669 Reduced 2.32%	660,430 $13.1 Million
Q1 2022 May 09, 2022	SELL	$21.94 - $42.51 $249,260 - $482,956	-11,361 Reduced 1.65%	676,099 $18.6 Million
Q4 2021 Feb 08, 2022	SELL	$36.09 - $53.79 $1.03 Million - $1.53 Million	-28,494 Reduced 3.98%	687,460 $28.3 Million
Q3 2021 Nov 12, 2021	SELL	$35.62 - $52.97 $390,787 - $581,133	-10,971 Reduced 1.51%	715,954 $33.3 Million
Q2 2021 Aug 11, 2021	SELL	$32.94 - $56.62 $728,105 - $1.25 Million	-22,104 Reduced 2.95%	726,925 $18.8 Million
Q1 2021 May 11, 2021	SELL	$44.47 - $81.38 $509,225 - $931,882	-11,451 Reduced 1.51%	749,029 $40.3 Million
Q4 2020 Feb 09, 2021	BUY	$32.49 - $61.88 $139,024 - $264,784	4,279 Added 0.57%	760,480 $37.2 Million
Q3 2020 Nov 12, 2020	SELL	$26.73 - $35.67 $683,646 - $912,295	-25,576 Reduced 3.27%	756,201 $24.6 Million
Q2 2020 Aug 07, 2020	SELL	$19.49 - $28.11 $383,699 - $553,401	-19,687 Reduced 2.46%	781,777 $20.2 Million
Q1 2020 May 08, 2020	SELL	$16.13 - $30.17 $466,237 - $872,063	-28,905 Reduced 3.48%	801,464 $19.5 Million
Q4 2019 Feb 06, 2020	SELL	$20.78 - $29.99 $1.15 Million - $1.66 Million	-55,435 Reduced 6.26%	830,369 $23.2 Million
Q3 2019 Nov 12, 2019	SELL	$23.87 - $30.93 $770,380 - $998,234	-32,274 Reduced 3.52%	885,804 $21.3 Million
Q2 2019 Aug 12, 2019	BUY	$22.1 - $28.56 $16.7 Million - $21.6 Million	754,988 Added 462.93%	918,078 $26.2 Million
Q1 2019 May 10, 2019	SELL	$12.0 - $25.76 $850,332 - $1.83 Million	-70,861 Reduced 30.29%	163,090 $4.08 Million
Q4 2018 Feb 12, 2019	BUY	$9.15 - $14.85 $2.14 Million - $3.47 Million	233,951 New	233,951 $2.94 Million

Others Institutions Holding VCYT

# of Institutions

320

Shares Held

80.6M

Call Options Held

134K

Put Options Held

13.3K

Black Rock Inc. New York, NY

7.79M
Shares

$324 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.75M
Shares

$322 Million
0.0% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

5.02M
Shares

$209 Million
0.27% of portfolio
Wellington Management Group LLP Boston, MA

4.23M
Shares

$176 Million
0.03% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

4.2M
Shares

$175 Million
1.46% of portfolio

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account